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Abstract 
The research presented here explored the role of endogenous opioid mechanisms in 
alcohol reinforcement. Alcohol was introduced to naïve mice under food deprivation or ad 
libitum food availability three times. Deprived and non-deprived mice were administered 
naloxone or vehicle after each exposure to ethanol or water. The animals were subsequently 
given a two bottle test of alcohol preference. The animals exposed to alcohol under deprivation 
and given vehicle showed a preference for alcohol over all other groups. Animals given naloxone 
after exposure to alcohol while deprived showed lower alcohol preference and did not differ 
from controls. These data show that the enhanced reinforcing and incentive effects of alcohol 
when initially presented under high food need is blocked by the opioid antagonist naloxone and 
suggests that these motivating effects of alcohol are mediated in part by endogenous opioid 
systems. Naloxone in suppression of alcohol preference and intake may be an effective tool in 
the treatment of alcohol addiction.  
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1.1 Statement of purpose 
Recent figures from the National Institute of Drug Addiction indicate that alcoholism 
affects upwards of 17.3 million Americans, more than 6% of the total population. (“Nationwide 
trends”, 2015), and that deleterious health outcomes for individuals struggling with alcoholism 
are a strain on our national healthcare system (“Excessive drinking is draining the U.S. 
economy”, 2016).  In order to create clinical programs that can cope more effectively with this 
issue, it’s essential to investigate not only the physiological changes that accompany addiction, 
but also the motivational changes that arise both as a consequence of and a determinant of 
addiction reinforcement. While current research has explored many of the external conditions 
that  motivate reinforcement in alcohol addiction (i.e. incentive mechanisms), our understanding 
of the internal mechanisms that mediate these motivational factors and how intervention might 
disrupt these mechanisms remains an important research issue. 
1.2 Defining addiction 
To understand how addiction develops and is reinforced is to stand at the crossroad of 
motivation where issues of need, want, liking and other behavioral states intersect with 
physiology, neurochemistry, and genetics. It is a complex state that is difficult to unravel. This is 
further complicated by the fact that alcohol is the only drug of abuse that provides nutritional 
value - delivering around 80 calories per ounce - and that nutritional content may constitute up to 
50% of the caloric intake of an alcohol dependent individual (Lewis, 1996). The mechanisms 
that mediate reinforcement of alcohol addiction are many and varied, and their study requires 
multiple behavioral and neurobiological approaches. 
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Neurochemical Mechanisms 
Many neurochemical systems are involved in the development and maintenance of 
addiction such as glutamate (D’Souza, 2015), GABA (Tan et al., 2011), and cannabinoids 
(Maldonado et al., 2006); however, dopamine (DA) has been implicated most widely in 
neurochemical accounts of addiction (Wise, 1980) and its continued study has produced the most 
consistent and reproduced models of addiction reinforcement. Originating in the ventral 
tegmental area (VTA) of the brain, DA neurons then ascend through the nucleus accumbens 
(NAc) and ventral striatum to the prefrontal cortex (PFC) (Berridge & Kringlebach, 2015). In 
this way, the mesocorticolimbic DA system connects that which is most reptilian in the brain 
with that which is most singularly human. DA receptors (DAR) types are differentiated by their 
mode of action: members of the D1 receptor family are G-coupled receptor proteins which 
increase the concentration of cAMP in the cell, whereas members of the D2 receptor family are 
G-coupled receptor proteins which inhibit the formation of cAMP in the cell (Carlson & Birkett, 
2016).  Both types have been implicated in reward, motivation and addiction (many references). 
A growing body of literature suggests that D2 receptor availability specifically plays a 
significant role in addiction. This includes genetic data: Bice et al. (2008) selectively bred high 
alcohol-preferring mice and then mapped their genome. Compared to control mice, high alcohol-
preferring mice expressed lower levels of the gene responsible for the production of the D2 
receptor. Additionally mice given chronic intermittent alcohol exhibit a massive loss of D2 
modulation (Trantham-Davidson et al., 2014). Finally, this hypothesis is bolstered by clinical 
data showing that Type II alcoholics show lower striatal D2 receptor availability than healthy 
controls (Volkow et al., 2002).      
While initially conceived of as the neurochemical most associated with pleasure in the 
brain, a waystation for the translation of stimulus into hedonic salience, many today believe that 
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DA may play a more limited motivational role (Berridge & Kringlebach, 2015). Some now 
believe that the mesocorticolimbic DA system may be a key part of our motivational system that 
encodes memories of reward experiences with events that preceded them (Volkow et al., 2017). 
With drugs of abuse like alcohol, the initial exposure produces an increase in striatal DA (Lewis, 
1996), phasic activation results in widespread downregulation of D2 receptors (Volkow et al., 
2017).  
D2 receptor availability not only mediates addiction but eating disorders as well. This is 
not surprising, given the fact that addiction and food intake share a common pathway by way of 
the mesocorticolimbic system via the hypothalamus (Volkow et al., 2011). VTA DA neurons 
express receptors instrumental in the homeostatic control of food intake such as leptin, amylin, 
and ghrelin (Volkow et al., 2017). Clinically, subjects with morbid obesity were found to have 
decreased striatal D2 levels (Volkow et al., 2008), and, furthermore, that chronic high-fat diet 
consumption decreased the brain reward threshold as a consequence of D2 receptor 
downregulation, leading to the individual consuming more of the diet in order to attain the same 
level of reward (Reyes, 2012). 
If changes in the DA system reflect changes in motivation, changes in hedonic tone may 
involve other mechanisms. Endogenous opioid systems have been hypothesized to play a role in 
the positive hedonic qualities of  motivational stimuli. Endogenous opioid receptors are of four 
types - three “classical” receptors (mu-opioid (MOP) receptor, delta-opioid (DOP) receptor, and 
kappa-opioid (KOP) receptor) and one “non-classical” receptor (nociceptin orphanin FQ peptide 
receptor) - and are present in high concentration, among other locations, along the mesolimbic 
and mesocortical pathways associated with reward and motivation (Nutt, 2014). Pro-
opiomelanocortin (POMC), a key opioid precursor, is of particular import to the study of 
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addiction: it gives rise to β-endorphin. A neural system which projects from the arcuate nucleus 
onto regions associated with the mesolimbic DA system such as the VTA and NAc, β-endorphin 
binds to both MOP and DOP (Gianoulakis, 2001).    
Research with other drugs of abuse (e.g. cocaine) has shown that activation of the D2 
system recruits activation of an endogenous opioid peptide that binds to MOP (Soderman & 
Unterwald, 2009). Likewise, ethanol diets have been shown to “cause an increase in the 
maximum number of both μ- and δ-receptors in experimental animals” (Herz, 1997). Also the 
release of endogenous opioid in response to ethanol administration is similar to that   of DA. 
Ethanol administration increases β-endorphin in the short-term which interacts with specific 
MOP and DOP receptors to mediate the neurobehavioral effect of the drug. Prolonged exposure 
to ethanol, however, results in a decreased β-endorphin release as an adaptive measure to 
counterbalance the effect of alcohol retain functioning at baseline levels which produces a 
hedonic change in the absence of ethanol (Gianoulakis, 2001). This change in hedonic quality 
may reflect neurochemical changes that occur with the development of physical dependence 
(withdrawal) with chronic administration of opioids. The presence of the withdrawal symptoms 
intensifies motivation leading to increased opioid intake and other aspects of additive behavior. 
Motivational Mechanisms 
The mechanisms in the development of addiction involve those that mediate changes with 
chronic administration (withdrawal) and motivation. One principle change is the activation of 
brain aversion systems that mediate negative hedonic effects produced by the absence of the drug 
of abuse. Whereas initial exposure activates positive reinforcement through increased DA and 
endogenous opioid receptor activation, prolonged exposure may lead to a homeostatic response 
to repetitive activation of reward systems producing aversion mediated by corticotropin-releasing 
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factor (CRF) and dynorphin in the amygdala. These responses are components of stress and may 
lead to other consequences in addition to aversion (Koob, 2017). 
Over time, consumption of drugs of abuse that may have started as goal-directed behavior 
becomes habitual, leading to a significant change in motivation and a resistance to devaluation of 
the stimulus. This is mirrored by the change in positive reinforcement (seeking positive hedonic 
effects) to negative reinforcement (avoidance of negative hedonic effects) (Koob & Volkow, 
2010). These motivational behavioral changes are enhanced by observed changes in neural 
connectivity: electrophysiological data of animals performing a food reinforced task showed 
dorsal medial striatum (DMS) activation during the acquisition phase of the experiment that 
transitioned to dorsal lateral striatum (DLS) activity during habitual performance (Everitt & 
Robbins, 2015). Changes in DLS DA signaling have been associated with cue-induced cocaine 
craving (Everitt & Robbins, 2015), and may represent a site of relevance to the negative affect 
that leads to feelings of need in avoidance of withdrawal.            
Changes in incentive relevance accompany and make possible changes in need to 
consume drugs of abuse: the importance of environmental cues associated with drugs of abuse 
reflects a neurochemical imbalance that directed consumption seeks to rectify. The 
neurochemical imbalance focuses and enhances the effects of environmental cues that are 
associated with consumption of the drug of abuse. In this respect, we can understand compulsive 
drug use as a need of a kind similar to the need for food. As has been explored previously, drug 
reward and motivation pathways share neural connectivity with pathways mediating food 
consumption. In the same way that nutritional deficit motivates food consumption behavior, 
mesolimbic D2 dysregulation can be conceptualized as creating a need that motivates drug 
consumption behavior (Atzram, 2015).   
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The way these systems interact with one another and create compounding effects can be 
seen in research on addiction reinforcement and deprivation. Studies using food deprivation and 
ethanol intake have been explored since 1901, but early explanations for increased ethanol 
consumption following deprivation attributed this outcome to alcohol’s caloric content; it wasn’t 
until the paradigm was used as part of an operant conditioning protocol that this was shown not 
to be the case, since ethanol drinking decreased but still remained higher than water consumption 
in control group rats when the intermittent schedule of food administration was removed and the 
animals were allowed to eat until sated (Carroll and Meisch, 1984). Indeed, the effect has been 
replicated with other drugs of abuse that do not have caloric content like stimulants and 
depressants, and there, too, a period of deprivation preceding drug administration increased 
intake (Meisch, 1984). The neurochemical explanation for this effect could be attributable to 
enhanced functional activity of DA receptors during food deprivation, either enhancing release, 
minimizing reuptake, or augmenting the D1 receptor pathway (Carr, 2002), which in turn enables 
an increased effect of D1/D2 synergism in the NAc (Hasbi et al., 2011).  
1.3 The C57Bl/6 Mouse 
The C57BL/6 mouse (C57) is the standard model for mouse research - not only is the 
strain possessing of a remarkable stability, widespread use, and is easily bred (Battey et al., 
1999), but for those very reasons it was selected as the first organism to have its genome 
recorded outside of humans. This popularity may have been motivated in part by to the strain’s 
outsized  preference for ethanol consumption. In a survey of voluntary ethanol consumption in 
15 commonly used inbred mouse strains, the C57 reigned supreme in the amount of ethanol 
consumed at low and high concentrations (3% and 10% respectively) in addition to exhibiting 
the lowest incidence of avoidance (Belknap et al., 1993).   
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Part of this effect can be explained by genotypic variation. Compared to DBA/2 mice, a 
strain with just as strong of an outsized avoidance for alcohol, the C57 mouse has a lower density 
of D2 receptor mRNA abundance in the hypothalamus (Ng et al., 1994), a finding consistent 
with assumptions of the DA hypothesis of addiction explored above.  
1.4 Naloxone antagonism of ethanol and reinforcement effects 
First patented in 1961 to treat constipation induced by chronic opioid use (“The history of 
naloxone”, 2017), naloxone is now widely used as an over the counter tool to reverse acute 
opioid overdose (“Is naloxone accessible?”, 2018). Naloxone acts as an opioid antagonist, 
reversing the effect of opioids by competing for the same binding sites with higher affinities and 
thereby resolving attendant central nervous system depression, sedation, and hypotension in an 
individual experiencing overdose (“Narcan prescribing information”, 2017). Naloxone is not a 
selective antagonist - though it has a predominantly high nanomolar affinity for MOP, it also 
demonstrates a nanomolar affinity for KOP (Nutt, 2014). 
Naloxone administration has been shown to modulate the reinforcing and motivational 
components of drugs of abuse (e.g. cocaine) in subjects as shown by Kuzmin et al. (1997). In 
their first experiment, mice were pre-treated with either naloxone, naloxone-methyl iodide 
(NMI) (a form of naloxone that does not cross the blood brain barrier), or saline solution before a 
period of self-administration of cocaine at graded doses. The administration of naloxone shifted 
the dose-response curve to the right, and significantly blunted the reinforcement effect (i.e. less 
self-administration) of 0.4µg cocaine at 1 mg/kg compared to both equal concentrations of 
placebo or NMI. Furthermore, 1mg/kg of naloxone had a significant effect on conditioned place 
preference for animals conditioned with 10 mg/kg cocaine, significantly decreasing the amount 
of time spent in the drug paired side of a two compartment box compared to equal concentrations 
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of placebo or NMI. Because neither of these effects were exhibited with the administration of 
NMI, the opioid blockade’s influence on reinforcement occurs centrally, not peripherally.   
Due to the close interrelation of the DA mesolimbic systems and endogenous opioid 
receptor systems explored above, naloxone has been explored as a potential avenue to interrupt 
patterns of alcohol dependence. Indeed, administration of opioid receptor agonists have been 
shown to increase ethanol consumption. Wild and Reid (1990) demonstrated that Sprague-
Dawley rats given intracerebroventricular doses of morphine consumed more ethanol than their 
vehicle counterparts during two bottle choice period following 22 hours of water deprivation, 
and that this effect is due to central, rather than peripheral, mechanisms in the brain. This effect 
is not confounded with other appetitive factors like sugar content; having been administered a 
subcutaneous dose of morphine, Sprague-Dawley rats have been shown to have an increased 
preference for a sweetened ethanol-sucrose solution over water during a two bottle choice period 
following 18 hours of food and water deprivation, but not for the sucrose solution without 
ethanol (Reid & Hunter, 1984).   
Non-specific opioid receptor antagonists have been shown to decrease both ethanol 
dependence and locomotor effects. In Swiss-Webster mice made physically dependent on 
alcohol via ethanol vapor exposure, those mice that had been given naloxone exhibited 
withdrawal behaviors 14 times less than those given a saline solution of equal volume, even 
though both groups had equivalent concentrations of blood alcohol (Blum et al., 1977). 
Moreover, mice (BALB/c, C57, or DBA/2) given a subcutaneous naltrexone (a non-specific 
opioid receptor antagonist similar to naloxone; like naloxone it has preferential binding for MOP 
and KOP, but has a higher affinity for DOP than naloxone (Nutt, 2014)) administration before 
being injected intraperitoneally with ethanol did not exhibit ethanol hypnosis compared to 
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experimental groups that received only saline injections and, with the exception of C57, did not 
exhibit loss of righting reflex following ethanol exposure (Kiianmaa et al., 1983).      
Non-specific opioid receptor antagonists alter ethanol preference. A 1mg/kg 
administration of naloxone in Wistrar rats following the development of behavioral dependence 
on ethanol acutely lowered ethanol consumption without affecting water consumption as part of 
a two bottle choice, whereas behaviorally dependent rats given saline demonstrated no difference 
in preference (Marfaing-Jallait et al., 1983). Likewise, subcutaneous naltrexone administration in 
C57 mice following 2 weeks of ethanol exposure as part of a continuous two bottle choice 
transiently reduced ethanol consumption and produced a long-lasting reduction in ethanol 
preference (Middaugh & Bandy, 2000). Additionally, naloxone has been shown to decrease 
motivation effects of alcohol. Rats implanted with lateral hypothalamic electrodes were 
operantly trained to self-administer brain stimulation; following a pre-test control session, the 
animals were then injected with saline or naloxone and then saline or ethanol and tested for 10 
minutes .5, .2, 3.5, and 5 hours following injection (Lorens & Sainati, 1978). Those subjects that 
received an ethanol and naloxone administration did not exhibit the increase in self-
administration present in those subjects that received an ethanol and saline administration. 
Because naloxone was not shown to affect blood alcohol level, this indicates that naloxone 
effectively blockaded the motivational effect of ethanol with regard to lateral hypothalamic self-
stimulation.  
2.1 Thesis Objectives 
 Endogenous opioids have been shown to play a significant role in motivation, 
enforcement and addictive behaviors. Moreover, they have been found to interact with other 
neurochemical systems in mediating alcohol behavioral and physiological effects. Opioid 
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antagonists have been shown to effectively interrupt preferential and motivational effects of 
alcohol consumption, and, by the same token, opioid agonists have been shown to effectively 
raise preferential effects .In the research explored above, the blunting effect of opioid blockade 
on the performance of extant addiction oriented behaviors has been demonstrated. What is of 
interest, however, is if naloxone can block the consolidation of addiction reinforcement in the 
first place, not only depressing preference or physical dependence with extant addiction, but 
rather the learning about reward salience mediated by activation of the mesocortical dopamine 
pathway during the first exposure to the drug of abuse.  
2.2 Subjects 
Subjects consisted of 25 C57 mice all of which had no prior ethanol exposure from 
Taconic Laboratories (New York, NY, USA). Subjects were individually housed in ventilated 
Plexiglas cages in a room maintained on a 12-12 reverse light dark cycle. The mean body weight 
was 28.8 grams. This study was conducted in accordance with guidelines of the Guide to the 
Care of the Use of Laboratory Animals, of the National Institutes of Mental Health. The animals 
were maintained on ad libitum food (lab chow) and water except for the 24 h before exposure to 
ethanol when food was withheld.  Animals were returned to ad libitum conditions at other times. 
Food deprivation was followed by two or three days of ad libitum food and water before each 
deprivation period.  
2.3 Procedure 
 Subjects were divided into four equal cohorts: two experimental cohorts, and two control 
cohorts. Members of the first experimental cohort (n = 5) received a 5 mg/kg administration of 
naloxone immediately after their first exposure to ethanol (2 cc of 3% ethanol), while members 
of the second experimental cohort (n = 5) received a 5 mg/kg administration of saline (2 cc 0.9% 
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NaC) vehicle immediately after their first exposure to ethanol (2 cc of 3% ethanol). The first of 
the control cohort (n = 5) received a 5 kg/mg administration of naloxone following the fasting 
period, but did not receive ethanol exposure. Likewise, the second control cohort (n = 5) received 
a 5mg/kg administration of saline solution, but did not receive ethanol exposure. After three days 
of exposure to ethanol under deprivation conditions accompanied by administrations of either 
vehicle or naloxone, subjects then resumed a chow diet and were run on a two bottle choice 
paradigm (Martinetti et al., 2000). One hour into the dark (active) cycle, each subject was 
presented with a bottle of water and a bottle of 10% v/v ethanol solution. For one hour, each 
subject was allowed to freely consume from either of the two bottles. The bottles, having been 
pre-weighed, were then collected and re-weighed to determine the difference. 
3.1 Statistical Analysis 
Ethanol consumed 
 It was hypothesized that subjects which had been administered naloxone immediately 
following ethanol exposure would consume less ethanol than subjects administered vehicle 
immediately following ethanol exposure during a two bottle choice test. A one-way analysis of 
variance (ANOVA) comparing the means of ethanol and water consumption supports this 
hypothesis. While there is no significant between groups difference in the amount of water 
consumed during the two-bottle choice test (F(3, 21) = 1.14, p = 0.36), there is a significant 
between groups difference for the amount of ethanol consumed (F(3, 21) = 13.64, p < 0.05).  
This difference is characterized by the outsized consumption of ethanol of the  
naloxone-/ethanol+ group (M = 2.44, SE = 0.26). Compared to each other group – 
naloxone+/ethanol+ (M = 1.00, SE = 0.07, p  < 0.01), naloxone+/ethanol- (M = 1.34, SE = 0.18, 
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p < 0.05), and naloxone-/ethanol- (M = 1.24, SE = 0.13, p < 0.05) – the naloxone-/ethanol+ 
group consumed a significantly larger amount of alcohol according to a Tukey’s range test.  
The naloxone-/ethanol+ group is also the only cohort to exhibit a significant difference in 
the amount of water and ethanol consumed within the group. An independent samples t-test 
shows that whereas the naloxone+/ethanol+ (p = 0.36, t = 0.99), naloxone+/ethanol- (p = 0.93, t 
= 0.09), and naloxone-/ethanol- (p = 0.13, t = 1.69) cohorts all had no statistically discrete 
difference in the amount of water and ethanol consumed, the naloxone-/ethanol+ cohort (p < 
0.01, t = 5.29) consumed significantly more ethanol than water. These data are summarized in 
figure 1 below. 
 
Figure 1: Figure 1 illustrates discrepancies in the amount of liquid consumed by each 
group, measured in grams, during the two-bottle choice test.  
 
Percent alcohol consumed 
It was hypothesized that subjects which had been administered naloxone immediately 
following ethanol exposure would not only consume less ethanol, but would consume less 
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ethanol preferentially (i.e. ethanol would represent a smaller fraction of the total amount of liquid 
consumed) than subjects which had been administered vehicle immediately following ethanol 
exposure during a two bottle choice test. The percent alcohol consumed for each group was 
calculated by taking the amount of ethanol consumed in grams and then dividing it by the total 
amount of liquid consumed in grams.  
A one-way ANOVA comparing percent alcohol consumed supports this hypothesis, but 
not globally. A significant between groups difference was found (F(3, 21) = 3.78, p < 0.05), but 
this held only for multiple comparisons between the naloxone-/ethanol+ cohort (M = 0.74, SE = 
0.03) and the naloxone+/ethanol+ cohort (M = 0.48, SE  = 0.09). There was no significant 
difference in percent alcohol consumed between any of the other cohorts according to a Tukey’s 
range test. These data are summarized in figure 2 below.  
 
Figure 2: Figure 2 illustrates discrepancies in the percentage of alcohol consumed by  
each group. Percent alcohol was determined by finding the ratio of alcohol consumed 
over the total of all liquid consumed by each subject. 
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3.2 General Discussion 
These data clearly indicate that naloxone appears to have a blunting effect on the 
consumption of alcohol, as seen in both less alcohol consumed and a greater proportion of water 
consumed. The naloxone+/ethanol+ cohort behaved indistinguishably from those groups that had 
never been exposed to alcohol in the first place. The key finding of these data, however, is that 
naloxone can disrupt the acquisition of the reinforcing effects of alcohol addiction during the 
initial exposure. Addiction is a process of the acquisition of new behaviors that are reinforced by 
the effects of the drug. The increased striatal dopamine induced by exposure to a drug of abuse 
creates an aberrantly powerful change in learning and memory compared to natural cues that 
leads to sensitivity to environmental cues associated with consumption of drugs of abuse 
(Torregrossa et al., 2011). Naloxone, as suggested by these data, interrupts that consolidation. 
The pretreatment of the naloxone+/ethanol+ cohort led to a lower alcohol consumption in 
comparison to animals that did not receive pretreatment: their relationship to alcohol during two 
bottle choice exposure was no different than that of either of the control groups. The 
naloxone+/ethanol+ cohort was in not particularly attentive to or motivated by the presence of 
alcohol. On the other hand, the naloxone+/ethanol+ cohort seemed, also, to express a lower need 
for alcohol consumption. This is reflected by the significant difference of ethanol consumption as 
a fraction of total liquid consumption. To this end, the naloxone+/ethanol+ group was the only 
cohort that differed in percent ethanol consumed from the naloxone-/ethanol+ cohort, and was 
the only cohort to have consumed a significant difference of ethanol and water within the group. 
In other words, members of the naloxone+/ethanol+ cohort had not only a lower preference for 
alcohol consumption, but also a lower drive to consume ethanol than their naloxone-/ethanol+ 
cohort counterparts. Both the external (enhanced incentive) and internal (need) components of 
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reinforcement were interrupted by the administration of naloxone and the attendant blockage of 
opioid receptors. 
This effect cannot be attributed to a difference in performance. Naloxone’s effect on 
locomotor changes induced by ethanol has been explored above. Naloxone administered before 
the exposure to ethanol could create changes in locomotor capacities that can be conflated with 
changes in motivation. Since naloxone was administered after exposure to ethanol, its effect on 
motivation cannot be confounded with locomotor changes.  
An interesting observation is the increase, though non-significant, of water consumption 
in the naloxone+/ethanol+ cohort. Across multiple animal models, naloxone has been found to 
decrease food and water consumption following deprivation (Foster et al., 1981; Brown & 
Holtzman, 1979). This appetitive decrease is tied to the primarily antidipsogenic action of 
naloxone, which seems to have been counteracted in part by the exposure of alcohol. It could be 
that the activation and dysregulation of appetitive systems that accompanies the development and 
reinforcement of alcohol addiction could be responsible for this increase in water consumption, 
but further research specifically investigating non-regulatory consumption of water is called for. 
These data suggest questions for future research endeavors. For example, is naloxone’s 
interruption of ethanol’s reinforcing effect dose dependent? A graded dose administration could 
better define the extent of this effect. Additionally, what is the timing of this effect - could 
naloxone blunt the reinforcing effect of ethanol after only one exposure? Is naloxone the best 
tool for this effect? Naltrexone has a longer tail in its effect window, and has different nanomolar 
affinities – would its administration produce the same outcome? Finally, there are observable 
differences in striatal DA between men and women (Perry et al., 2016) - is there a discrepancy in 
the extent of this effect between sexes?      
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Future clinical research could also emphasize the use of naloxone as a potential 
therapeutic tool for decreasing incentive mechanisms and drive components of alcohol and other 
drugs of abuse as well as the treatment of obesity. Naloxone has been used in interventions 
reversing the effects of alcoholic coma (Lyon & Anthony, 1982), so clinical applications have 
already been explored. Naloxone could very well be folded into clinical rehabilitation protocols 
in order to create extinction of incentive value during detoxification, for example, and aid in the 
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